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SUMMARY: ALA is the precursor of EPA and DHA and its dietary availability is limited. Vegetable oils rich in 
ALA (48–64%) are alternatives for increasing its consumption. The conversion of ALA into EPA and DHA and 
the ratio (EPA+DHA/ALA) was evaluated in different tissues from male Wistar rats fed ALA –rich oils. Four 
groups (n=12/group) were fed for 21 days with oils from: a) corn (CO, 3% ALA); b) soybean (SO, 6% ALA); 
c) sacha inchi (SIO, 48% ALA) and; d) chia (ChO, 64% ALA). SO, SIO and ChO significantly increased ALA 
levels (p<0.05) in the tissues. Only SIO and ChO increased tissue EPA and DHA while reducing n-6/n-3 ratio 
(p<0.05). SIO and ChO are suggested as good sources of ALA to increase tissue EPA and DHA.
KEYWORDS: Alpha linolenic acid; Chia oil; Docosahexaenoic acid; Eicosapentaenoic acid; n-3 LCPUFA; Sacha inchi oil
RESUMEN: Aceites vegetales ricos en ácido alfa linolénico permiten un mayor almacenamiento de AGPICL n-3 
en el plasma, hígado y tejido adiposo de la rata. ALA es precursor de EPA y DHA y sus fuentes dietarias son 
limitadas. Aceites ricos en ALA (48–64%) son una alternativa para incrementar su consumo. En este trabajo se 
evaluó la conversión de ALA a EPA y DHA, y la relación (EPA+DHA/ALA) en tejidos de ratas macho Wistar 
alimentadas con aceites con alto contenido en ALA. Cuatro grupos (n=12/grupo) recibieron durante 21 días 
aceite de: a) maíz (CO, 3% ALA); b) soja (SO, 6% ALA); c) sacha inchi (SIO, 48% ALA) y; d) chía (ChO, 64% 
ALA). SO, SIO y ChO incrementaron ALA (p<0,05) en los tejidos. Solo SIO y ChO incrementaron el EPA y 
DHA, disminuyendo la relación n-6/n-3 (p<0,05). Se propone SIO y ChO como fuentes de ALA para incre-
mentar EPA y DHA en los tejidos.
PALABRAS-CLAVE: Aceite de chía; Aceite de sacha inchi; Ácido alfa linolénico; Ácido docosahexaenoico; Ácido eicos-
apentaenoico; AGPICL n-3
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1. INTRODUCTION
Polyunsaturated fatty acids (PUFA), are very 
important for humans especially during pregnancy, 
breastfeeding and early life (Burlingame et al., 2009). 
Linoleic (C18:2 n-6, LA) and alpha linolenic (C18:3 
n-3, ALA) fatty acids are essentials to humans and 
other species which do not have the enzymes to 
synthesize these fatty acids so that both fatty acids 
must be supplied from the diet. However, humans 
can elongate and de-saturate both fatty acids syn-
thesizing long chain polyunsaturated fatty acids 
(LCPUFA) of C20 and C22, which have impor-
tant and essential functions in the body (Holman 
and Johnson, 1982). The most important LCPUFA 
obtained from ALA are eicosapentaenoic acid 
(C20:5 n-3, EPA) and docosahexaenoic acid (C22:6 
n-3, DHA). Different reports have established the 
cardioprotective effects of EPA and DHA when 
provided from fish, fish oil, or other dietary sup-
plements (De Caterina, 2011). The importance of 
DHA in the brain and visual development has also 
been demonstrated (Valenzuela et al., 2006) and the 
neuroprotective role of this fatty acid during aging 
and the development of neurodegenerative diseases 
(Valenzuela et al., 2012a). Arachidonic acid (C20:4 
n-6, ARA), a LCPUFA derived from LA also has 
a significant function in developing nervous tissue, 
especially in the brain, immune system, and vascu-
lar endothelial homeostasis (Hoffman et al., 2009). 
Dietary recommendations establish the importance 
of an adequate intake of n-3 and n-6 fatty acids 
(Simopoulos, 2008). However, the technological 
development experienced during the twentieth cen-
tury has modified food production and consump-
tion around the world, but especially in western 
countries (Hunter, 1989), where the food sources 
of n-3 PUFA (ALA) and n-3 LCPUFA (EPA and 
DHA) are very limited, with abundant sources of 
LA (the majority of consumed oils are good sources 
of LA). On the contrary, few sources of ALA are 
massively available for consumption, with the excep-
tion of soybean (6% ALA) and canola oils (10% 
ALA). The availability of EPA and DHA is even 
more restrictive due to a low consumption of fish in 
western countries (Simopoulos, 2008; Mozaffarian 
and Wu, 2011). Fatty fish, such as tuna, mackerel, 
salmon, sardine and anchovy, are the best dietary 
sources of EPA and DHA (Mozaffarian and Wu, 
2011). This situation has produced changes in the 
consumption of essential fatty acids with modifi-
cations in n-6/n-3 PUFA ratios, which are, at pres-
ent, among the most significant nutritional changes 
in the western diet, leading to a dietary imbalance 
in the n-6/n-3 LCPUFA ratio which ranges from 
15 to 20: 1 while 5:1 is the recommended ratio 
(Simopoulos, 1999). n-6/n-3 LCPUFA imbalance 
represents a significant change when compared 
with the historical  relationship of n-6/n-3 LCPUFA 
consumed by humans for thousands of years (van 
Vliet and Katan, 1990). A direct metabolic effect of 
this nutritional situation is the increase in the n-6/
n-3 PUFA ratio of membrane phospholipids with a 
predominant formation of ARA derivatives which 
have pro-inflammatory and coagulant activity, and 
increase the prevalence of inflammatory illness 
and cardiovascular and cerebrovascular mortality 
(Simopoulos, 2009).
Recent industrialization and commercial avail-
ability in Latin America of ancestral oils, such as 
sacha inchi and chia oil, which have high a con-
tent of ALA, open the possibility of providing the 
population with abundant and inexpensive sources 
of n-3 PUFA. Sacha inchi oil (42 to 48% ALA) is 
obtained from the fruit Plukenetia volubilis, known 
as Inca Peanut (native from Peru) (Maurer et al., 
2012). Chia oil (60 to 65% ALA) is obtained from 
the seed Salvia hispanica or chia seed (native from 
Mexico and Guatemala) (Espada et al., 2007). 
These oils could be considered new and innovative 
food sources of ALA, which may improve the dras-
tic imbalance in the n-6/n-3 LCPUFA ratio of the 
western population (Simopoulos, 1999; Simopoulos, 
2008). However, it remains to be demonstrated that 
the ingestion of greater amounts of ALA, i.e. pro-
vided by sacha inchi or chia oil, is reflected in the 
effective tissue accretion of n-3 LCPUFAs EPA and 
DHA. The objective of this study was the evaluation 
of the modification in the levels of n-3 LCPUFAs 
EPA and DHA in the plasma, hepatic and adipose 
tissue and to establish the product (EPA+DHA)/
precursor (ALA) ratio in Wistar rats after feeding 
with oils rich in ALA (sacha inchi and chia oil). 
2. MATERIALS AND METHODS
2.1. Animals and Diets
Male Wistar rats (21 day-old) were obtained from 
the Bioterium of the Nutrition Department of the 
Faculty of Medicine, University of Chile. Animals 
were randomly assigned to one of four groups with 
free access to the different experimental diets (n=12 
animals/experimental group). Each group was fed 
with an isocaloric diet, with a macronutrient dis-
tribution: 20% protein, 10% fat and 70% carbohy-
drates, supplemented with micronutrients according 
to the nutritional requirements of Wistar rats. The 
total fat in each group was exclusively provided by a 
vegetable oil according to the following description: 
corn oil (CO, 3 % ALA); soybean oil (SO, 6% ALA); 
sacha inchi oil (SIO, 48% ALA); chia oil (ChO, 64% 
ALA). Dietary composition was previously pub-
lished (González-Mañán et al., 2012). The fatty acid 
composition of each diet is shown in Table 1. The 
dietary intervention was applied for 21 days, with 
the animals having free access to food and water. At 
the end of the experimental period, the animals were 
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made to fast overnight and at 8:00 AM  anaesthetized 
by an intraperitoneal injection (1mL·kg−1, a mix-
ture of 25 mg·mL−1 zolazepam chlorhydrate and 25 
mg·mL−1 tiletamine chlorhydrate, Zoletil 50, Virbac 
S A, Carros, France). Blood samples were obtained 
by cardiac puncture and plasma and erythrocytes 
were separated by centrifugation of whole blood at 
1500 g for 5 min. Liver and adipose tissue (visceral 
fat) were extracted from each rat, placed immediately 
into chilled sample vials and frozen at −80 °C for 
further fatty acid analysis. All procedures were per-
formed according to the institutional guidelines for 
research with animals established by the Bioethics 
Committee of the Faculty of Medicine, University 
of Chile (Protocol number CBA# 0654 FMUCH). 
2.2. Tissue lipid extraction and separation
Quantitative extraction of total lipids from 
plasma, hepatic and adipose tissue was carried out 
according to Bligh and Dyer (Bligh and Dyer, 1959) 
in the presence of BHT (butylated hydroxytoluene) 
as antioxidant. Plasma and tissue samples were sus-
pended in ice-cold chloroform/methanol (2:1 v/v) 
containing 0.01% BHT and magnesium chloride 
(0.5 N) and homogenized in an Ultraturrax homog-
enizer (Janke & Kunkel, Stufen, Germany). The 
organic phase containing total lipids was separated 
for further analysis.
2.3. Preparation of fatty acid methyl ester (FAME)
FAME from plasma, hepatic and adipose tissue 
total lipids were prepared with methanolic boron 
trifluoride (12% methanolic solution) according to 
Morrison and Smith (Morrison and Smith, 1964). 
FAME samples were cooled and extracted with 
0.5 mL of hexane. 
2.4. FAME gas-liquid chromatography 
FAME were separated and quantified by gas-liq-
uid chromatography using Hewlett-Packard equip-
ment (model 7890A, CA, USA) equipped with a 
capillary column (Agilent HP-88, 100 m×0.250 mm; 
I.D. 0.25 μm) and a flame ionization detector (FID). 
The injector temperature was set at 250 °C and the 
FID temperature at 300 °C. The oven temperature 
at injection was initially set at 140 °C and was pro-
grammed to increase to 220 °C at a rate of 5 °C·min−1. 
Hydrogen was used as carrier gas. FAME identifica-
tion and quantification was achieved using a com-
mercial lipid standard (Nu-Chek Prep Inc. MN, 
USA.) and C23:0 as internal standard (Nu-Chek 
Prep Inc. MN, USA.) using the Hewlett-Packard 
Chemstation Data System.   
2.5. Statistical analysis
Statistical analysis was performed with the 
GraphPad Prism 5.1 software (GraphPad Prism 
Software, Inc. San Diego, USA). The values 
shown represent the mean±SEM for the number 
of  separate experiments indicated. The evalua-
tion of  normality data distribution was performed 
using the Shapiro Wilk test. Assessment of  the sta-
tistical significance of  differences between mean 
values was performed by one-way ANOVA and 
the Newman-Keuls test. A p<0.05 was considered 
significant. 
3. RESULTS 
3.1. Weight increase and food intake 
No significant differences, either in the initial or 
in the final weight or  dietary intake of the animals 
from each group during the 21 days of interven-
tion was observed (not shown). Also, no significant 
 differences in liver weight or in subcutaneous adi-
pose tissue aspect were observed. No mortality was 
produced during the experimental period.
3.2.  Plasma fatty acid composition
  The composition of  the most relevant fatty 
acids of  total plasma lipids are shown in Table 2. 
It can be observed that total saturated fatty acids 
(SFA) and total monounsaturated fatty acids 
(MUFA) were not modified by the oils. Total 
PUFA and total LCPUFA were increased only in 
ChO when compared to CO. Total n-6 LCPUFA 
were significantly increased in CO, compared to 
SO, SIO and ChO, with this group showing a dras-
tic reduction in this value compared to the other 
groups. Total n-3 LCPUFA were significantly 
higher in SO, SIO and ChO when compared to 
CO. However, the value for ChO was significantly 
TABLE 1. Fatty acid composition of each diet: corn oil 
(CO), soybean oil (SO), sacha inchi oil (SIO) and chia 
oil (ChO). Values show the mean of five analyses and are 
expressed as g FAME per 100 g of diet
Fat content CO SO SIO ChO
SFA 1.5 1.4 0.6 0.9
MUFA 2.7 2.5 1.0 0.6
Oleic acid 2.3 2.3 0.8 0.5
PUFA 6.2 6.0 8.5 8.5
Total n-6 PUFA 5.8 5.3 3.5 2.1
Linoleic acid 5.7 5.1 3.6 2.0
Total n-3 PUFA 0.4 0.7 4.9 6.4
Alpha linolenic acid 0.3 0.6 4.8 6.3
EPA n/d n/d n/d n/d
DHA n/d n/d n/d n/d
n6/n-3 PUFA ratio 14.5 0.0 0.7 0.3
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higher than SO and SIO. When individual n-6 
and n-3 fatty acids were compared, significant 
differences were observed in all groups. LA was 
significantly higher in CO and SO compared to 
SIO and ChO. No differences were observed when 
CO and SO, and SIO and ChO were compared, 
respectively. ALA was significantly higher in SIO 
and ChO when compared to the other groups. 
However, the ALA for ChO showed the highest 
value among the experimental groups. AA showed 
the highest value in CO compared to SO, SIO and 
ChO. In contrast, ChO showed the lowest value 
for AA. EPA was increased in SO, SIO and ChO , 
when compared to CO. However, ChO showed a 
remarkable increment for EPA with respect to the 
other groups. DHA increased in SO, SIO and ChO 
when compared to CO. However, SIO and ChO 
showed the same level of  DHA, which is different 
from the behavior observed for EPA for the same 
experimental groups. The highest n-6/n-3 ratio was 
obtained for CO, and in contrast, the lowest ratio 
was obtained for ChO. 
3.3. Liver fatty acid composition
  The composition of the most relevant fatty acids 
of total liver lipids is shown in Table 3. It can be 
observed that total SFA and total PUFA were not 
modified when the different experimental groups 
were compared. Total MUFA were significantly 
increased and total LCPUFA were significantly 
reduced in SO as compared to ChO. Although total 
PUFA was not modified, significant differences 
were observed when fatty acids were individually 
compared. LA showed the highest value in CO and 
the lowest value in ChO. In contrast, the values for 
ALA were highest in ChO and very low in CO, the 
other oils showed intermediate values. AA increases 
with the amount of LA provided by the diets, hav-
ing a high value in CO and the lowest value in ChO. 
EPA and DHA showed the same behavior as the 
one observed in plasma, with the lowest values in 
CO and the highest values in ChO. Again, no differ-
ences were observed for DHA when SIO and ChO 
were compared. The n-6/n-3 LCPUFA ratio was 
drastically modified in SO, SIO and ChO as com-
pared to CO. The highest n-6/n-3 ratio for LCPUFA 
was obtained for CO, in contrast, ChO showed the 
smallest ratio, with SO and SIO having intermediate 
values for this ratio.
3.4. Adipose tissue fatty acid composition 
The composition of the most relevant fatty acids 
of total lipids extracted from adipose tissue is shown 
in Table 4. Although the absolute values for total 
SFA, MUFA, PUFA and LCPUFA were different 
from those observed in the liver, all these parame-
ters showed the same tendency in each group as was 
observed for both adipose tissue and liver. The same 
observation is valid for the individual fatty acids of 
major relevance. Again, no significant differences 
were observed for DHA in SIO or ChO, whereas 
the values for EPA in ChO were notably different, 
such as was observed in the liver. The ratio n-6/n-3 
LCPUFA also showed the same behavior as in the 
liver, but values were not extremely different as was 
observed for this last tissue. 
TABLE 2. Most relevant fatty acids obtained from plasma samples of the different experimental groups
Fatty acid
Groups
CO (a) SO (b) SIO (c) ChO (d) 
Total SFA 55.6±5.1 52.1±4.7 50.4±3.7 47.8±5.2
Total MUFA 16.9±2.4 16.5±2.5 15.2±1.8 14.4±1.8
Total PUFA 27.5±3.6d 31.4±4.3 34.4±2.8 37.8±4.8a
Total LCPUFA 7.84±0.9d 7.11±0.8 11.1±1.4 11.6±1.5a
Total n-6 LCPUFA 7.31±0.8b,c,d 3.42±0.5a,d 4.00±0.6a,d 1.50±0.08a,b,c
Total n-3 LCPUFA 0.30±0.04b,c,d 3.71±0.6a,c,d 7.10±1.2a,b,d 10.1±1.1a,b,c
18:2, n-6 (LA) 20.4±3.2c,d 19.2±2.6c,d 6.83±0.4a,b 3.61±0.7a,b
18:3, n-3 (ALA) 0.18±0.02b,c,d 5.31±0.7a,c,d 16.8±2.6a,b,d 22.2±3.4a,b,c
20:4, n-6 (AA) 7.12±1.9b,c,d 2.90±0.4a,d 3.70±0.3a,d 1.10±0.2a,b,c
20:5, n-3 (EPA) 0.16±0.02b,c,d 2.62±0.3a,c,d 4.20±0.8a,b,d 6.12±1.2a,b,c
22:6, n-3 (DHA) 0.13±0.03a,c,d 0.83±0.05a,c,d 2.21±0.2a,b 2.71±0.6a,b
n-6/ n-LCPUFA3 ratio 24.3±1.4b,c,d 0.91±0.04a,c,d 0.60±0.03a,b,d 0.20±0.02a,b,c
Values are expressed as g fatty acid per 100 g FAME and represent the mean±SEM for n=12 rats/experimental group. Values sharing 
the same letter in each row are not statistically different (p<0.05). Saturated fatty acids (SFA) correspond to 14:0, 16:0 and 18:0. 
Monounsaturated fatty acids (MUFA) correspond to 14:1, n-7, 16:1, n-7 and 18:1, n-9. Polyunsaturated fatty acids (PUFA) correspond 
to 18:2, n-6, 18:3, n-3, 20:4, n-6, 20:5, n-3, 22:5, n-3, and 22:6, n-3; n-6 Long chain polyunsaturated fatty acids (LCPUFA) are 20:4, n-6; 
n-3 LCPUFA are 20:5, n-3, 22:5, n-3, and 22:6, n-3; n-6/n-3 ratio: 20:4, n-6/ (20:5, n-3+22:5, n-3+22:6, n-3). 
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3.5.  Product/precursor ratio (n-3 LCPUFA/n-3 
PUFA) in plasma, liver and adipose tissue
The plasma, liver and adipose n-3 LCPUFA 
(EPA+DHA)/n-3 PUFA (ALA) ratio is shown 
in Figure 1. It can be observed that for all tissues 
(A:  plasma; B: liver; C: adipose tissue) the lowest 
ALA supply (CO) results in the highest (EPA+DHA/
ALA) ratio. On the contrary, the highest supply of 
ALA results in the lowest (EPA+DHA/ALA) ratios, 
as is observed for SO, SIO and ChO. 
4. DISCUSSION
The data presented show that the intake of ALA, 
when provided in higher amounts by the different 
vegetable oils, may increase ALA content and n-3 
LCPUFA (EPA + DHA) content in the plasma, 
TABLE 3. Most relevant fatty acids obtained from liver samples of the different experimental groups 
Fatty acid
Groups
CO (a) SO (b) SIO (c) ChO (d) 
Total SFA 33.1±2.2 33.6±2.1 34.2±3.8 34.4±2.5
Total MUFA 18.4±1.8 19.6±1.4d 17.7±2.5 15.8±1.2b
Total PUFA 48.5±4.2 46.8±3.5 48.1±4.3 49.1±3.4
Total LCPUFA 21.4±2.2 17.1±2.4d 21.8±3.2 22.4±2.1b
Total n-6 LCPUFA 19.6±1.6b,c,d 9.65±1.1a,d 6.70±1.4a,b 2.41±0.4a,b,c
Total n-3 LCPUFA 1.80±0.2b,c,d 7.45±0.5a,c,d 15.0±1.6a,b,d 20.0±1.4a,b,c
18:2, n-6 (LA) 24.2±4.2c,d 20.6±2.5c,d 12.36±1.3a,b,d 5.04±0.3a,b,c
18:3, n-3 (ALA) 0.31±0.05b,c,d 5.10±0.6a,c,d 12.4±1.3a,b,d 17.6±1.6a,b,c
20:4, n-6 (AA) 15.8±1.7b,c,d 7.11±0.4a,c,d 5.50±2.6a,d 1.81±0.3a,b,c
20:5, n-3 (EPA) 0.26±0.1b,c,d 3.22±0.5a,c,d 5.62±0.7a,b,d 9.02±0.5a,b,c
22:6, n-3 (DHA) 1.15±0.2b,c,d 3.15±0.3a,c,d 5.91±0.6a,b 6.22±0.8a,b
n-6/n-3 LCPUFA ratio 10.9±1.1b,c,d 1.30±0.2a,c,d 0.45±0.1a,b,d 0.12±0.02a,b,c
Values are expressed as g fatty acid per 100 g FAME and represent the mean±SEM for n=12 rats/experimental group. Values sharing 
the same letter in each row are not statistically different (p<0.05). Saturated fatty acids (SFA) correspond to 14:0, 16:0 and 18:0. 
Monounsaturated fatty acids (MUFA) correspond to 14:1, n-7, 16:1, n-7 and 18:1, n-9. Polyunsaturated fatty acids (PUFA) correspond 
to 18:2, n-6, 18:3, n-3, 20:4, n-6, 20:5, n-3, 22:5, n-3, and 22:6, n-3; n-6 Long chain polyunsaturated fatty acids (LCPUFA) are 20:4, n-6; 
n-3 LCPUFA are 20:5, n-3, 22:5, n-3, and 22:6, n-3; n-6/n-3 ratio: 20:4, n-6/ (20:5, n-3+22:5, n-3+22:6, n-3). 
TABLE 4. Most relevant fatty acids obtained from adipose tissue samples of the different experimental groups
Fatty acid
Groups
CO (a) SO (b) SIO (c) ChO (d) 
Total SFA 58.1±4.1 60.1±3.8 57.8±3.4 57.1±4.2
Total MUFA 21.3±3.6 20.0±2.1 19.9±1.8 20.0±3.6
Total PUFA 20.6±3.4 19.9±1.8 22.3±2.4 22.9±2.8
Total LCPUFA 6.60±1.4 5.80±1.1d 7.68±1.8 9.80±1.5b
Total n-6 LCPUFA 5.93±1.1c,d 4.41±0.5c,d 2.47±0.3a,b 1.87±0.5a,b,
Total n-3 LCPUFA 0.67±0.02b,c,d 1.39±0.05a,c,d 5.21±0.6a,b,d 7.93±1.1a,b,c
18:2, n-6 (LA) 13.6±2.4c,d 11.4±2.6c,d 4.71±0.5a,b,d 1.84±0.4a,b,c
18:3, n-3 (ALA) 0.24±0.03b,c,d 2.73±0.5a,c,d 8.61±1.1a,b 10.6±1.6a,b
20:4, n-6 (AA) 5.91±1.3 4.32±0.7 2.46±0.3a,b 1.81±0.5a,b
20:5, n-3 (EPA) 0.01±0.001b,c,d 0.46±0.1a,c,d 0.92±0.2a,b,d 2.88±0.3a,b,c
22:6, n-3 (DHA) 0.41±0.03b,c,d 0.94±0.1a,c,d 4.22±0.5a,b 4.74±0.4a,b
n-6/n-3 LCPUFA ratio 8.85±1.6b,c,d 3.17±0.4a,c,d 0.47±0.1a,b,d 0.24±0.05a,b,c
Values are expressed as g fatty acid per 100 g FAME and represent the mean±SEM for n=12 rats/experimental group. Values sharing 
the same letter in each row are not statistically different (p<0.05). Saturated fatty acids (SFA) correspond to 14:0, 16:0 and 18:0. 
Monounsaturated fatty acids (MUFA) correspond to 14:1, n-7, 16:1, n-7 and 18:1, n-9. Polyunsaturated fatty acids (PUFA) correspond 
to 18:2, n-6, 18:3, n-3, 20:4, n-6, 20:5, n-3, 22:5, n-3, and 22:6, n-3; n-6 Long chain polyunsaturated fatty acids (LCPUFA) are 20:4, n-6; 
n-3 LCPUFA are 20:5, n-3, 22:5, n-3, and 22:6, n-3; n-6/n-3 ratio: 20:4, n-6/ (20:5, n-3+22:5, n-3+22:6, n-3). 
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liver and adipose tissue of animals fed SO, SIO and 
ChO. The tissue levels of each of the n-3 LCPUFA 
studied increased with the amount of ALA provided 
by each of the dietary oils, with sacha inchi oil and 
chia oil showing higher ALA, EPA and DHA tissue 
contents when compared to corn oil and soybean 
oil (Tables 2, 3, 4). As the dietary oils do not con-
tain EPA or DHA, the increase in these fatty acids 
in the tissues must result from the animals’ capac-
ity to transform ALA into its metabolic derivatives. 
Desaturation and elongation of ALA occurs mainly 
in the liver, therefore this fatty acid, once absorbed, 
must be transported to the liver to be elongated and 
desaturated, first to EPA and after to DHA (Wang 
et al., 2005). Although these fatty acids accumulate 
in the liver, they are also transported to other tissues, 
such as blood (erythrocytes and white cells) and adi-
pose tissue. EPA normally competes with ARA to 
be incorporated into membrane phospholipids (Sun 
et al., 2008), an effect that is notorious when higher 
amounts of ALA are provided, such as in the case of 
ChO. Less competence is observed for SO and SIO, 
but irrelevant for CO. DHA is almost exclusively 
accumulated in the brain, retina and gonads (Innis 
and Dyer, 2002; Barceló-Coblijn et al., 2005). The 
presence of this n-3 LCPUFA in the liver reflects the 
active conversion of ALA into DHA, and its pres-
ence in plasma shows its active transport to the tar-
get tissues. Normally, adipose tissues do not show 
relevant amounts of n-3 LCPUFA when dietary 
ALA is provided in low amounts (Barceló-Coblijn 
and Murphy, 2009), as was observed for CO in our 
protocols. However, as the amount of dietary ALA 
is increased, adipose tissue responds by increasing 
its content of ALA and also its content of EPA and 
DHA, probably acting as a metabolic reservoir for 
these fatty acids. Although we have not evaluated the 
activity of hepatic elongase and desaturase enzymes, 
we suggest that the presence of higher amounts of 
ALA stimulates its conversion to EPA and DHA, at 
the same time that it competes for tissue deposition 
of AL and its transformation into ARA by the same 
enzymes (Wang et al., 2006). However, when com-
paring the product/precursor ratio (EPA+DHA/
ALA) (Figure 1) it is observed that the  supply of 
the precursor (ALA) was lower, and the ratio with 
the product was greater (EPA+DHA). It is interest-
ing that SO, which provided a low amount of ALA 
(0.6g ALA·100g−1 diet), shows an (EPA+DHA 
/ ALA) ratio similar to the ratio obtained for the diets 
which provided high amounts of ALA (SIO 4.8g 
ALA·100g−1 diet; ChO 6.3g ALA·100g−1 diet). This 
situation may indicate that the enzymes involved in 
this transformation (hepatic elongases and desatu-
rases) may be saturated even at low ALA concentra-
tions, an effect that has been previously described 
for these enzymes (Nakamura and Nara, 2004). 
Therefore, further studies are needed to evaluate the 
possible modification in both the expression and the 
activity of the enzymes involved in the metabolic 
transformation of ALA to n-3 LCPUFA, such as 
Δ-5 and Δ-6 desaturase enzymes, when the fatty acid 
is provided in high amounts, as occurs with SIO and 
ChO in our experimental protocols. Therefore, our 
results may suggest that the metabolic route for the 
conversion of ALA to n-3 LCPUFA is saturated 
when ALA is provided in relatively higher amounts.
The reduction in the n-6 (AA)/n-3 LCPUFA 
(EPA+DHA) ratio observed for SIO and ChO (Tables 
2, 3, 4) may have health benefits, particularly in the 
western diet because a higher n-6/n-3 ratio is asso-
ciated with pro-inflammatory status (Simopoulos, 
2009) and major incidence of chronic diseases, such 
FIGURE 1. Product/precursor ratio [(EPA+DHA)/ALA] for 
plasma (A), liver (B) and adipose tissue (C) obtained after 
CO, SO, SIO and ChO supplementation. 
Values sharing the same letter in each row are not
statistically different (p<0.05).
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as cardiovascular diseases (Simopoulos, 2009; De 
Caterina, 2011) and non-alcoholic fatty liver disease 
(Valenzuela and Videla, 2011).
The product/precursor ratio shown in Figure 1 
demonstrates that although a higher supply of ALA 
results in a greater accretion of EPA and DHA in 
the tissues studied, only a limited amount of ALA 
is transformed to n-3 LCPUFA, as may be con-
cluded from the product/precursor ratios obtained 
for SO, SiO and ChO. This effect may reflect a regu-
latory mechanism that operates in this conversion, 
mainly in the control of the activity of ∆-5 and ∆-6 
desaturase enzymes, the main limiting pathway of 
this metabolic route. It has being proposed that less 
than 5% of ALA is transformed to DHA (Swanson 
et al., 2012), and that EPA, which is an intermedi-
ary into the transformation of ALA to DHA, is 
 tissue-accumulated only when the fatty acid is sup-
plied as such (i.e from marine organisms) (Arterburn 
et al., 2006). 
Sacha inchi and chia oils have been demonstrated 
to be very good sources of ALA to be further trans-
formed into EPA and DHA by the liver, transported 
through the plasma and accumulated in the adipose 
tissue. Although this accumulative effect remains to 
be demonstrated in humans, it is interesting to spec-
ulate that these vegetable oils, which are now indus-
trially produced in many Latin American countries, 
should be a good and inexpensive way to supply 
the population with ALA to be transformed into 
EPA and DHA. Consumption of sacha inchi and/
or chia oils may compensate the very low ingestion 
of ALA, and also the low ingestion of n-3 LCPUFA 
(EPA+DHA) from marine origin, as occurs in some 
countries such as Chile, Colombia, Argentine, the 
highlands of Peru, the rain forest of Brazil and 
other regions of South America (Valenzuela et al., 
2012b). We are currently studying the effect of chia 
oil supplementation in the milk content of DHA in 
nursing women.  
5. CONCLUSIONS
Feeding rats with diets containing higher amounts 
of ALA, allows for its accretion into different tis-
sues and its conversion to n-3 LCPUFA (EPA and 
DHA), which are also accreted in the plasma, liver 
and adipose tissue of the animals. Oils with a high 
content of ALA, such as sacha inchi and chia oils 
may be a good alternative for providing n-3 PUFA 
to be metabolically transformed into n-3 LCPUFA, 
an efficient and inexpensive way to nutritionally 
obtain these essential and low available fatty acids. 
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